-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
December 20, 2011 - or NT-pro-BNP test’s ability to predict
morbidity and mortality in HF patients, as well as whether therapies … The review will
examine whether therapies involving BNP and NT-proBNP improve outcomes in HF patients … risk of coronary artery disease (CAD), with CAD, other
adults at risk of HF without documented HF (diabetes … For KQ6, we will also extract a description of treatment arms (usual care, guided
therapy, other); … based on clinical judgment with
regards to comparability of study populations, diagnostic standard, treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
February 01, 2012 - associated with a
higher risk of weight gain, elevated lipid
and prolactin levels, and development of
type 2 diabetes … Food and Drug
Administration (FDA) approved
risperidone and aripiprazole for the
treatment of irritability … The object is to help
consumers, health care providers, and
others in making informed choices
among treatment … Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … • Treatment naïve versus history of previous
antipsychotics use?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
August 27, 2012 - the group (practice)
were able to do this or, even more, how patients were
able to pick their own treatments … there was
randomization at the practice level,
providers could break that randomization
and select treatments … Not entirely sure what QI + [therapy] [meds] means,
especially when the other construction uses -. … Meds are a form of therapy, so the distinction was
lost on me. … We have
replaced “QI+Therapy” and “QI+Meds” with
“QI-Therapy” and “QI-Meds”.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/sodium-potassium_research-protocol.pdf
April 18, 2017 - Among subpopulations defined by hypertension, diabetes, and obesity health
status.
2. … Among subpopulations defined by hypertension, diabetes, and obesity health
status.
3. … Among subpopulations defined by hypertension, diabetes, and obesity health
status.
7. … Blood pressure lowering in type 2 diabetes: a systematic
review and meta-analysis. … PTCA, CVD mortality, total
mortality)
Adjustment factors for
observational studies e.g.,
clinic, treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-pancreas_research-protocol.pdf
August 09, 2013 - percent.5
Risk factors for pancreatic cancer include tobacco use; a personal history of pancreatitis,
diabetes … between these populations
and burden of disease may be related to higher rates of cigarette smoking and diabetes … that some Stage III cases are borderline resectable and may be appropriate targets
for neoadjuvant therapy … adenocarcinoma is fatal if untreated, so it is critical to choose the right imaging
test and initiate therapy … Were the study results unaffected by intervening treatments or disease
progression/regression?
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
January 01, 2007 - Analytic framework for evaluating the effectiveness and safety of treatments for renal
artery stenosis … Stents were used only rarely and medical therapies varied both
between and within studies. … were prospective, followed the
natural history of 721 patients who mostly received various medical therapies … Including a third RCT with a substantial treatment crossover (medical therapy
to angioplasty) at 3 months … , US
Department of Health and Human
Services/National Institutes of Health/National
Institute of Diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
November 07, 2023 - challenge
for other medical conditions such as hyperlipidemia and diabetes. … Public Comment
#1 (NCHR)
Introduction We agree with the AHRQ analysis of the data regarding treatments … whether benefits were
attributable to disulfiram
(beyond the benefits of
additional counseling or
therapeutic … whether benefits were
attributable to disulfiram
(beyond the benefits of
additional counseling or
therapeutic … this outcome under
potential benefits because
we want to look for
evidence regarding
whether the treatments
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_white-paper.pdf
September 01, 2013 - contributed clinical data to provide information on “real world” practice and the effectiveness of
treatments … registries currently exist for a wide range of
chronic or rare conditions, including many forms of cancer, diabetes … recruit patients for clinical trials to learn about a particular
disease or condition; to develop therapeutics … PPRs have also added to disease and treatment knowledge. … • Research across conditions/concomitant treatments.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cardiology-health-outcomes_research.pdf
July 01, 2010 - Care Program Research Report Number 30
Introduction
Carotid endarterectomy has been the recommended treatment … publication of several randomized studies in the
1990s comparing carotid endarterectomy with medical therapy … The
overall rate of revascularization did not increase, even with the introduction of a new therapeutic … Ongoing clinical trials will provide critical guidance for the treatment of
patients who are eligible … Carotid surgery versus medical therapy in
asymptomatic carotid stenosis.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/continuous-outcomes-quantitative-synthesis_methods.pdf
March 01, 2011 - For
example, in a study evaluating glycemic control in patients with type 2 diabetes,
4
patients … Statistical methods for analysis
of effects of treatment in overviews of
randomized trials. … Long-
Acting Beta2-Agonist and Inhaled
Corticosteroid Combination Therapy for
Adult Persistent Asthma … Effectiveness in
All Ages; and Variability in Prevalence,
Diagnosis, and Treatment. … Meta-analysis: effect of monotherapy and
combination therapy with inhibitors of the
renin angiotensin
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_research-2012-1.pdf
January 01, 2012 - about
Innovative Methods in Stakeholder Engagement: An Environmental Scan 9
the effects of treatments … The JLA uses a sequence of steps to prioritize unanswered questions about treatments
submitted by patients … Thus, DiabetesMine
helped set the agenda in the diabetes device marketplace with a very small up-front … This allows them
to capture physician insights into treatments, medications, and devices to inform … The James Lind Alliance: Tackling treatment uncertainties together.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/case-management-future_research.pdf
June 01, 2015 - Patients with
medical illness
and complex
care needs
Quality of Care
• Adherence to therapy
• Missed … patients have more than
one chronic condition or a complex condition that requires complex multiple treatments … Often
the treatments and services needed are not integrated into a coherent system of care. … the recent
Patients with
medical illness
and complex
care needs
Quality of Care
• Adherence to therapy … studies that compare CM with different
components such as factorial designs or
studies with multiple treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_disposition-comments.pdf
September 01, 2011 - Peer Reviewer 1 KQ3
(Maternal
Harms)
The occurrence of gestational diabetes should be reported when … Likewise, “therapy discontinuation” is
confusing. … Since we could not compare
gestational diabetes between terbutaline by
pump and other tocolytics from … that ought to be emphasized is
the inclusion of pharmacokinetic and pharmacodynamic measures
within treatment … treatment or no treatment shows low confidence that the
evidence reflects a true effect”.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
February 01, 2012 - The treatment choice that is the basis of this
review is whether to add pharmacologic therapy in the … form of BH4 or LNAAs to dietary therapy. … As noted, this report focuses
on the use of adjuvant treatments for PKU and does not
address dietary … controlled
and nonadherent populations, and among different age
groups, for both types of adjuvant therapies … Phenylketonuria:
Dietary and therapeutic challenges. J Inherit Metab Dis. 2007
Apr;30(2):145-52.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_executive.pdf
September 01, 2011 - maintenance therapy to prevent subsequent
episodes. … Effectiveness Reviews,
the program supports systematic
appraisals of existing scientific
evidence regarding treatments … No clear first-line
maintenance tocolytic therapy has yet emerged. … 1 13
No comparison group 2 22,23
Primary Tocolytic IV magnesium sulfate only 1 23
Treatments IV magnesium … nonsignificant differences between the
SQ terbutaline pump and oral terbutaline in the
incidence of gestational diabetes
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/fibromyalgia_research-protocol.pdf
April 03, 2014 - exercise program, cognitive behavioral therapy and
pharmaceutical therapy when indicated.1,17 Complementary … o Active
§ Exercise: supervised or independent (aerobic, strength training, stretching,
water/therapeutic … • Other therapies
o Mind-body therapies: meditation, hypnosis, tai chi, visualization
o Other … and
implementation (treatment fidelity) for nonpharmacologic treatments. … Journal of Manipulative & Physiological Therapeutics. 2011 Sep;34(7):483-96. PMID
21875523.
19.
-
effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
December 01, 2013 - As the first class of
new therapies for HCV treatment in 20 years and the first class of direct-acting … used only
after other treatments fail … As the first class of new therapies for HCV-infection treatment in 20 years and
the first class of … treatments
would significantly shift treatment or management models. … therapy was five prior to treatment.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
February 26, 2013 - was compared with optimal medical therapy. … was compared with optimal medical
therapy. … Treating low-risk lesions
could lead to additional invasive tests or
treatments that could adversely … of the rising
costs of health care and continued focus on improved
outcomes and appropriate use of therapies … Some of these characteristics include the percentage of
patients with hypertension, diabetes, previous
-
effectivehealthcare.ahrq.gov/sites/default/files/fleisher.pdf
January 01, 2010 - information overload
• Although social support is an important component, content is also critical in treatment … PA_Nav_Net
o Facebook
Slide
26: Untitled
Image of Pathways to Recovery
After Breast Cancer
Treatment
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c_surveillance.pdf
December 01, 2015 - Information about these
treatments were not assessed in this surveillance report. … Robert Gish, MD
University of San Diego
San Diego, CA
Averell Sherker, MD
National Institute of Diabetes … What is the comparative effectiveness of antiviral treatments in improving intermediate
outcomes, … KQ 2a and b:
What is the comparative effectiveness of antiviral treatments in improving
intermediate … Triple therapy in treatment-experienced patients with HCV-cirrhosis
in a multicentre cohort of the French